PHGDH: A Key Enzyme in Cellular Metabolism and Signaling (G26227)

Target Name: PHGDH

NCBI ID: G26227

PHGDH

PHGDH: A Key Enzyme in Cellular Metabolism and Signaling

PHGDH, also known as 3-phosphoglycerate dehydrogenase, is a protein that is expressed in various tissues throughout the body. It is a key enzyme in the citric acid cycle, which is a central metabolic pathway that is involved in the production of energy from food.

PHGDH is a 12-kDa protein that is localized to the endoplasmic reticulum (ER) and the cytoplasm. It is a member of the superfamily of ATP-binding proteins, which are a group of enzymes that are involved in the transfer of ATP to various cellular processes.

One of the unique features of PHGDH is its ability to catalyze the conversion of 3-phosphoglycerate (3PG) to 2-phosphoglycerate (2PG). This reaction is critical for the first step of the citric acid cycle, which is the production of ATP from ADP and phosphate.

By catalyzing the conversion of 3PG to 2PG, PHGDH helps to regulate the rate at which ATP is produced from the beginning of the citric acid cycle. This is important for maintaining the proper balance of ATP and ADP in the cell, which is critical for a wide range of cellular processes.

Another important function of PHGDH is its role in the detoxification of xenobiotics, such as bacteria, viruses, and other harmful substances that can enter the cell. Xenobiotics can cause damage to the cell and contribute to a variety of diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

PHGDH is also involved in the regulation of cellular signaling pathways. It has been shown to play a role in the regulation of cell adhesion, cell signaling, and the modulation of gene expression.

In addition to its role in cellular metabolism and signaling, PHGDH is also a potential drug target. Several studies have suggested that PHGDH may be a promising target for the treatment of a variety of diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

One approach to targeting PHGDH is to inhibit its activity with small molecules, such as drugs that can bind to specific regions of the protein. This can be done either by blocking the activity of PHGDH itself or by inhibiting the activity of the enzymes that it regulates.

Another approach to targeting PHGDH is to target its downstream targets, such as the molecules that are regulated by PHGDH. This can be done by inhibiting the activity of these molecules, which would result in the downstream regulation of PHGDH activity.

In conclusion, PHGDH is a protein that plays a critical role in the regulation of cellular metabolism and signaling pathways. Its activity is involved in the production of ATP from the beginning of the citric acid cycle and in the detoxification of xenobiotics. It is also a potential drug target, with several studies suggesting that it may be a promising target for the treatment of a variety of diseases. Further research is needed to fully understand the role of PHGDH in cellular processes and its potential as a drug target.

Protein Name: Phosphoglycerate Dehydrogenase

Functions: Catalyzes the reversible oxidation of 3-phospho-D-glycerate to 3-phosphonooxypyruvate, the first step of the phosphorylated L-serine biosynthesis pathway. Also catalyzes the reversible oxidation of 2-hydroxyglutarate to 2-oxoglutarate and the reversible oxidation of (S)-malate to oxaloacetate

The "PHGDH Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PHGDH comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets